Denoyelle C - Search Results

1

Development of optimized cytotoxicity assays for assessing the antitumor potential of CAR-T cells.

Eugene-Norbert M, Cuffel A, Riou G, Jean L, Blondel C, Dehayes J, Bisson A, Giverne C, Brotin E, Denoyelle C, Poulain L, Boyer O, Martinet J, Latouche JB. Eugene-Norbert M, et al. Among authors: denoyelle c. J Immunol Methods. 2024 Feb;525:113603. doi: 10.1016/j.jim.2023.113603. Epub 2023 Dec 24. J Immunol Methods. 2024. PMID: 38147898

2

Bcl-XL and MCL-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis.

Brotin E, Meryet-Figuière M, Simonin K, Duval RE, Villedieu M, Leroy-Dudal J, Saison-Behmoaras E, Gauduchon P, Denoyelle C, Poulain L. Brotin E, et al. Among authors: denoyelle c. Int J Cancer. 2010 Feb 15;126(4):885-95. doi: 10.1002/ijc.24787. Int J Cancer. 2010. PMID: 19634140

3

Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells.

Simonin K, Brotin E, Dufort S, Dutoit S, Goux D, N'diaye M, Denoyelle C, Gauduchon P, Poulain L. Simonin K, et al. Among authors: denoyelle c. Mol Cancer Ther. 2009 Nov;8(11):3162-70. doi: 10.1158/1535-7163.MCT-09-0493. Epub 2009 Nov 3. Mol Cancer Ther. 2009. PMID: 19887550

4

Downregulation of Bcl-xL and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy.

Varin E, Denoyelle C, Brotin E, Meryet-Figuière M, Giffard F, Abeilard E, Goux D, Gauduchon P, Icard P, Poulain L. Varin E, et al. Among authors: denoyelle c. Carcinogenesis. 2010 Jun;31(6):984-93. doi: 10.1093/carcin/bgq026. Epub 2010 Feb 8. Carcinogenesis. 2010. PMID: 20142415

5

miR-491-5p-induced apoptosis in ovarian carcinoma depends on the direct inhibition of both BCL-XL and EGFR leading to BIM activation.

Denoyelle C, Lambert B, Meryet-Figuière M, Vigneron N, Brotin E, Lecerf C, Abeilard E, Giffard F, Louis MH, Gauduchon P, Juin P, Poulain L. Denoyelle C, et al. Cell Death Dis. 2014 Oct 9;5(10):e1445. doi: 10.1038/cddis.2014.389. Cell Death Dis. 2014. PMID: 25299770 Free PMC article.

6

An overview of long non-coding RNAs in ovarian cancers.

Meryet-Figuière M, Lambert B, Gauduchon P, Vigneron N, Brotin E, Poulain L, Denoyelle C. Meryet-Figuière M, et al. Among authors: denoyelle c. Oncotarget. 2016 Jul 12;7(28):44719-44734. doi: 10.18632/oncotarget.8089. Oncotarget. 2016. PMID: 26992233 Free PMC article. Review.

7

The mTORC1/2 Inhibitor AZD8055 Strengthens the Efficiency of the MEK Inhibitor Trametinib to Reduce the Mcl-1/[Bim and Puma] ratio and to Sensitize Ovarian Carcinoma Cells to ABT-737.

Pétigny-Lechartier C, Duboc C, Jebahi A, Louis MH, Abeilard E, Denoyelle C, Gauduchon P, Poulain L, Villedieu M. Pétigny-Lechartier C, et al. Among authors: denoyelle c. Mol Cancer Ther. 2017 Jan;16(1):102-115. doi: 10.1158/1535-7163.MCT-16-0342. Epub 2016 Dec 15. Mol Cancer Ther. 2017. PMID: 27980105

8

Updates and current challenges in microRNA research for personalized medicine in ovarian cancer.

Mandilaras V, Vernon M, Meryet-Figuière M, Karakasis K, Lambert B, Poulain L, Oza A, Denoyelle C, Lheureux S. Mandilaras V, et al. Among authors: denoyelle c. Expert Opin Biol Ther. 2017 Aug;17(8):927-943. doi: 10.1080/14712598.2017.1340935. Epub 2017 Jun 22. Expert Opin Biol Ther. 2017. PMID: 28641048 Review.

9

Atelocollagen-mediated in vivo siRNA transfection in ovarian carcinoma is influenced by tumor site, siRNA target and administration route.

Meryet-Figuière M, Lecerf C, Varin E, Coll JL, Louis MH, Dutoit S, Giffard F, Blanc-Fournier C, Hedir S, Vigneron N, Brotin E, Pelletier L, Josserand V, Denoyelle C, Poulain L. Meryet-Figuière M, et al. Among authors: denoyelle c. Oncol Rep. 2017 Oct;38(4):1949-1958. doi: 10.3892/or.2017.5882. Epub 2017 Aug 4. Oncol Rep. 2017. PMID: 28791387 Free PMC article.

10

Antitumor activity of nanoliposomes encapsulating the novobiocin analog 6BrCaQ in a triple-negative breast cancer model in mice.

Sauvage F, Fattal E, Al-Shaer W, Denis S, Brotin E, Denoyelle C, Blanc-Fournier C, Toussaint B, Messaoudi S, Alami M, Barratt G, Vergnaud-Gauduchon J. Sauvage F, et al. Among authors: denoyelle c. Cancer Lett. 2018 Sep 28;432:103-111. doi: 10.1016/j.canlet.2018.06.001. Epub 2018 Jun 5. Cancer Lett. 2018. PMID: 29883750

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters